Pharmacokinetics and pharmacodynamics of six epoetin alfa dosing regimens in anemic critically ill patients without acute blood loss. (åpner nytt vindu)

Arroliga AC, Guntupalli KK, Beaver JS, Langholff W, Marino K, Kelly K

Kilde‎: Crit Care Med 2009;37(4):1299-307.

Arkiv‎: PubMed 19242343

DOI‎: 10.1097/CCM.0b013e31819cec94

https://www.ncbi.nlm.nih.gov/pubmed/19242343 (åpner nytt vindu)

Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. (åpner nytt vindu)

Ball AM, Winstead PS.

Kilde‎: Pharmacotherapy 2008;28(11):1383-90.

Arkiv‎: PubMed 18956998

DOI‎: 10.1592/phco.28.11.1383

https://www.ncbi.nlm.nih.gov/pubmed/18956998 (åpner nytt vindu)

Reducing postburn injury anemia in a Jehovah's Witness patient. (åpner nytt vindu)

Barsun A, Sen S, Palmieri TL, Greenhalgh DG

Kilde‎: J Burn Care Res 2014;35(4):e258-61.

Arkiv‎: PubMed 24121804

DOI‎: 10.1097/BCR.0b013e3182a366c5

https://www.ncbi.nlm.nih.gov/pubmed/24121804 (åpner nytt vindu)

A US multicenter, retrospective, observational study of erythropoiesis-stimulating agent utilization in anemic, critically ill patients admitted to the intensive care unit. (åpner nytt vindu)

Brophy GM, Sheehan V, Shapiro MJ, Lottenberg L, Scarlata D, Audhya P; ASSESS Study Group and Amgen Inc

Kilde‎: Clin Ther 2008;30(12):2324-34.

Arkiv‎: PubMed 19167591

DOI‎: 10.1016/j.clinthera.2008.12.024

https://www.ncbi.nlm.nih.gov/pubmed/19167591 (åpner nytt vindu)

Severe acute anemia after liver transplantation in an elderly Jehovah's Witness treated with high-dose erythropoietin and ferric carboxymaltose: a case report. (åpner nytt vindu)

Brunetta DM, Kaufman J, De Santis GC, Mesquita DF, Souza FN, Garcia JH.

Kilde‎: Transplant Proc 2015;47(8):2548-51.

Arkiv‎: PubMed 26518969

DOI‎: 10.1016/j.transproceed.2015.09.014

https://www.ncbi.nlm.nih.gov/pubmed/26518969 (åpner nytt vindu)

Recombinant human erythropoietin in severe anaemia: issues of dosing and duration. (åpner nytt vindu)

Charles A, Purtill M, Napolitano LM.

Kilde‎: Anaesth Intensive Care 2006;34(6):793-6.

Arkiv‎: PubMed 17183900

https://www.ncbi.nlm.nih.gov/pubmed/17183900 (åpner nytt vindu)

Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. (åpner nytt vindu)

Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, Colton T, Corwin MJ.

Kilde‎: Crit Care Med 1999;27(11):2346-50.

Arkiv‎: PubMed 10579246

https://www.ncbi.nlm.nih.gov/pubmed/10579246 (åpner nytt vindu)

Erythropoietin for critically ill trauma patients: a missed opportunity? (åpner nytt vindu)

Corwin HL, Napolitano LM

Kilde‎: J Trauma Acute Care Surg 2014;77(5):774-9.

Arkiv‎: PubMed 25494432

DOI‎: 10.1097/TA.0000000000000442

https://www.ncbi.nlm.nih.gov/pubmed/25494432 (åpner nytt vindu)

Postoperative management of severe acute anemia in a Jehovah's Witness. (åpner nytt vindu)

de Araújo Azi LM, Lopes FM, Garcia LV

Kilde‎: Transfusion 2014;54(4):1153-7.

Arkiv‎: PubMed 24117834

DOI‎: 10.1111/trf.12424

https://www.ncbi.nlm.nih.gov/pubmed/24117834 (åpner nytt vindu)

Restrictive transfusion in geriatric trauma patients. (åpner nytt vindu)

DeLeon AN, Uecker JM, Stafford SV, Ali S, Clark A, Brown CV

Kilde‎: Am Surg 2016;82(1):85-8.

Arkiv‎: PubMed 26802863

https://www.ncbi.nlm.nih.gov/pubmed/26802863 (åpner nytt vindu)

High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome. (åpner nytt vindu)

Gabriel A, Kozek S, Chiari A, Fitzgerald R, Grabner C, Geissler K, Zimpfer M, Stockenhuber F, Bircher NG

Kilde‎: J Trauma 1998;44(2):361-7.

Arkiv‎: PubMed 9498512

DOI‎: 10.1097/00005373-199802000-00023

https://www.ncbi.nlm.nih.gov/pubmed/9498512 (åpner nytt vindu)

Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]. (åpner nytt vindu)

Georgopoulos D, Matamis D, Routsi C, Michalopoulos A, Maggina N, Dimopoulos G, Zakynthinos E, Nakos G, Thomopoulos G, Mandragos K, Maniatis A; Critical Care Clinical Trials Greek Group.

Kilde‎: Crit Care 2005;9(5):R508-15.

Arkiv‎: PubMed 16277712

DOI‎: 10.1186/cc3786

https://www.ncbi.nlm.nih.gov/pubmed/16277712 (åpner nytt vindu)

Management of a Jehovah's Witness patient with sepsis and profuse bleeding after emergency coronary artery bypass graft surgery: rethinking the critical threshold of oxygen delivery. (åpner nytt vindu)

Hong T, Shander A, Agarwal S, Castresana M.

Kilde‎: A A Case Rep 2015;4(10):127-31.

Arkiv‎: PubMed 25974416

DOI‎: 10.1213/XAA.0000000000000144

https://www.ncbi.nlm.nih.gov/pubmed/25974416 (åpner nytt vindu)

Management strategies for perioperative anaemia in the severely burn-injured Jehovah's Witness patients who decline a blood transfusion: a systematic review with illustrative case reports. (åpner nytt vindu)

Jung M, Harish V, Wijewardena A, Kerridge I, Gillies R

Kilde‎: Burns. 2023 49(3):716-29. Epub 2022 Jul 18.

Arkiv‎: PubMed 35941026

DOI‎: 10.1016/j.burns.2022.07.002

https://pubmed.ncbi.nlm.nih.gov/35941026/ (åpner nytt vindu)

Long-term ECMO treatment in Jehovah's Witness patient without transfusions. (åpner nytt vindu)

Lindholm J, Palmér K, Frenckner B.

Kilde‎: Perfusion 2012;27(4):332-4.

Arkiv‎: PubMed 22496111

DOI‎: 10.1177/0267659112444328

https://www.ncbi.nlm.nih.gov/pubmed/22496111 (åpner nytt vindu)

Outcomes with the use of recombinant human erythropoietin in critically ill burn patients. (åpner nytt vindu)

Lundy JB, Hetz K, Chung KK, Renz EM, White CE, King BT, Huzar T, Wolf SE, Blackbourne LH

Kilde‎: Am Surg 2010;76(9):951-6.

Arkiv‎: PubMed 20836341

https://www.ncbi.nlm.nih.gov/pubmed/20836341 (åpner nytt vindu)

Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis. (åpner nytt vindu)

Mesgarpour B, Heidinger BH, Schwameis M, Kienbacher C, Walsh C, Schmitz S, Herkner H.

Kilde‎: Intensive Care Med 2013;39(11):1896-908.

Arkiv‎: PubMed 23928897

DOI‎: 10.1007/s00134-013-3030-9

https://www.ncbi.nlm.nih.gov/pubmed/23928897 (åpner nytt vindu)

Transfusion-free treatment strategies for acute anemia in critical care. (åpner nytt vindu)

Morgan CA, Byul Sarah S, Forest CP.

Kilde‎: JAAPA 2016;29(8):38-44.

Arkiv‎: PubMed 27467297

DOI‎: 10.1097/01.JAA.0000488695.96294.33

https://www.ncbi.nlm.nih.gov/pubmed/27467297 (åpner nytt vindu)

Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. (åpner nytt vindu)

Napolitano LM, Fabian TC, Kelly KM, Bailey JA, Block EF, Langholff W, Enny C, Corwin HL.

Kilde‎: J Trauma 2008;65(2):285-97.

Arkiv‎: PubMed 18695463

DOI‎: 10.1097/TA.0b013e31817f2c6e

https://www.ncbi.nlm.nih.gov/pubmed/18695463 (åpner nytt vindu)

Reticulocyte counts and their relation to hemoglobin levels in trauma patients. (åpner nytt vindu)

Otterman ML, Nijboer JM, van der Horst IC, van Meurs M, ten Duis HJ, Nijsten MW

Kilde‎: J Trauma 2009;67(1):121-4.

Arkiv‎: PubMed 19590320

DOI‎: 10.1097/TA.0b013e318187a848

https://www.ncbi.nlm.nih.gov/pubmed/19590320 (åpner nytt vindu)

Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. (åpner nytt vindu)

Pieracci FM, Henderson P, Rodney JR, Holena DN, Genisca A, Ip I, Benkert S, Hydo LJ, Eachempati SR, Shou J, Barie PS.

Kilde‎: Surg Infect (Larchmt) 2009;10(1):9-19.

Arkiv‎: PubMed 19245362

DOI‎: 10.1089/sur.2008.043

https://www.ncbi.nlm.nih.gov/pubmed/19245362 (åpner nytt vindu)

How do we treat life-threatening anemia in a Jehovah's Witness patient? (åpner nytt vindu)

Posluszny JA Jr, Napolitano LM.

Kilde‎: Transfusion 2014;54(12):3026-34.

Arkiv‎: PubMed 25330835

DOI‎: 10.1111/trf.12888

https://www.ncbi.nlm.nih.gov/pubmed/25330835 (åpner nytt vindu)

Recombinant human erythropoietin use in a critically ill Jehovah's Witness after cardiac surgery. (åpner nytt vindu)

Price S, Pepper JR, Jaggar SI.

Kilde‎: Anesth Analg 2005;101(2):325-7.

Arkiv‎: PubMed 16037136

DOI‎: 10.1213/01.ANE.0000159158.70532.D0

https://www.ncbi.nlm.nih.gov/pubmed/16037136 (åpner nytt vindu)

Successful rescue therapy for severe acute anemia: managing the critically ill Jehovah's Witness. (åpner nytt vindu)

Rebel A, Beck A, Efron P, Bavry AA, Ang D.

Kilde‎: Am Surg 2015;81(6):e263-5.

Arkiv‎: PubMed 26031262

https://www.ncbi.nlm.nih.gov/pubmed/26031262 (åpner nytt vindu)

Erythropoietin response is blunted in critically ill patients. (åpner nytt vindu)

Rogiers P, Zhang H, Leeman M, Nagler J, Neels H, Mélot C, Vincent JL

Kilde‎: Intensive Care Med 1997;23(2):159-62.

Arkiv‎: PubMed 9069000

DOI‎: 10.1007/s001340050310

https://www.ncbi.nlm.nih.gov/pubmed/9069000 (åpner nytt vindu)

Life-threatening postoperative blood loss in a Jehovah's Witness, treated with high-dose erythropoietin. (åpner nytt vindu)

Schälte G, Janz H, Busse J, Jovanovic V, Rossaint R, Kuhlen R.

Kilde‎: Br J Anaesth 2005;94(4):442-4.

Arkiv‎: PubMed 15653706

DOI‎: 10.1093/bja/aei068

https://www.ncbi.nlm.nih.gov/pubmed/15653706 (åpner nytt vindu)

Management of anemia in patients who decline blood transfusion. (åpner nytt vindu)

Shander A, Goodnough LT

Kilde‎: Am J Hematol 2018;93(9):1183-91.

Arkiv‎: PubMed 30033541

DOI‎: 10.1002/ajh.25167

https://pubmed.ncbi.nlm.nih.gov/30033541/ (åpner nytt vindu)

Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study. (åpner nytt vindu)

Talving P, Lustenberger T, Inaba K, Lam L, Mohseni S, Chan L, Demetriades D.

Kilde‎: Arch Surg 2012;147(3):251-5.

Arkiv‎: PubMed 22430906

DOI‎: 10.1001/archsurg.2011.1838

https://www.ncbi.nlm.nih.gov/pubmed/22430906 (åpner nytt vindu)

Intravenous iron following cardiac surgery does not increase the infection rate. (åpner nytt vindu)

Torres S, Kuo YH, Morris K, Neibart R, Holtz JB, Davis JM.

Kilde‎: Surg Infect (Larchmt) 2006;7(4):361-6.

Arkiv‎: PubMed 16978079

DOI‎: 10.1089/sur.2006.7.361

https://www.ncbi.nlm.nih.gov/pubmed/16978079 (åpner nytt vindu)

Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial. (åpner nytt vindu)

Tsai TH, Lu CH, Wallace CG, Chang WN, Chen SF, Huang CR, Tsai NW, Lan MY, Sung PH, Liu CF, Yip HK

Kilde‎: Crit Care 2015;19:49.

Arkiv‎: PubMed 25888250

DOI‎: 10.1186/s13054-015-0761-8

https://www.ncbi.nlm.nih.gov/pubmed/25888250 (åpner nytt vindu)

Pharmacotherapy for reducing RBC transfusion for patients in the ICU: a systematic review and network meta-analysis. (åpner nytt vindu)

Yoshihiro S, Hongo T, Yamamoto M, Taito S, Kataoka Y

Kilde‎: Crit Care Med 2024;52(4):618-25.

Arkiv‎: PubMed 37962159

DOI‎: 10.1097/CCM.0000000000006114

https://pubmed.ncbi.nlm.nih.gov/37962159/ (åpner nytt vindu)